EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Clinical trial NCT02309411 · COMPLETED

Trial details

NCT number: NCT02309411
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2015-01-15
Primary completion: 2017-04-05
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.